DataMeds AI, Inc. Net Change in Cash
DataMeds AI, Inc. (MEDS) reported Net Change in Cash of $2.41 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-17
- DataMeds AI, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was $9.16K, a 99.38% decline year-over-year.
- DataMeds AI, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $1.49M, a 411.01% increase year-over-year.
- DataMeds AI, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $291.24K.
- DataMeds AI, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$985.76K, a 195.99% decline from fiscal 2024.
- DataMeds AI, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $1.03M, a 75191.20% increase from fiscal 2023.
- DataMeds AI, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $1.36K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.41M 10-Q · filed 2026-08-17 | |||
| 2026-03-31 | $9.16K 10-Q · filed 2026-05-19 | |||
| 2025-12-31 | -$985.76K 10-K · filed 2026-03-20 | |||
| 2025-09-30 | $3.20M 10-Q · filed 2025-11-19 | |||
| 2025-06-30 | -$608.39K 10-Q · filed 2026-08-17 | |||
| 2025-03-31 | $1.49M 10-Q · filed 2026-05-19 | |||
| 2024-12-31 | $1.03M 10-K · filed 2026-03-20 | |||
| 2024-09-30 | $791.78K 10-Q · filed 2025-11-19 | |||
| 2024-06-30 | $65.61K 10-Q · filed 2025-08-19 | |||
| 2024-03-31 | $291.24K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $1.36K 10-K · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |